What is a MitraClip Procedure? 

The mitral valve is a vital component of the heart, acting as a one-way gate that ensures blood flows in the right direction. When this valve fails to close properly, a condition known as mitral regurgitation occurs, allowing blood to leak backward and forcing the heart to work harder. Traditionally, the only way to fix a leaky mitral valve was through major open-heart surgery. However, the MitraClip procedure a minimally invasive ‘keyhole’ alternative has transformed treatment for those who are unable to undergo traditional surgery. This article explains how this innovative technology works and who is eligible for the procedure in the UK. 

What We’ll Discuss in This Article 

• The clinical definition of a MitraClip procedure and how it works. 

• The step-by-step process of transcatheter edge-to-edge repair (TEER). 

• Who qualifies for the procedure according to UK clinical guidelines. 

• The primary causes of mitral regurgitation treated by MitraClip. 

• The benefits of a less invasive approach compared to open-heart surgery. 

• Recovery timelines and what to expect after the intervention. 

How the MitraClip Procedure Treats a Leaky Mitral Valve? 

A MitraClip procedure, clinically known as transcatheter edge-to-edge repair (TEER), is a minimally invasive treatment for a leaky mitral valve. It involves placing a small, clothespin-like clip onto the flaps (leaflets) of the mitral valve to help them close more tightly. Unlike traditional surgery, the heart is reached through a thin tube (catheter) inserted into a vein in the groin, meaning the chest does not need to be opened and the heart does not need to be stopped. 

In the UK, the procedure is used to reduce the amount of blood leaking backward into the lungs. By clipping the leaflets together, the device effectively stops or significantly reduces the leak, improving the heart’s efficiency and relieving symptoms. 

• Minimally Invasive: Access is gained via the femoral vein in the leg. 

• Edge-to-Edge Repair: The device ‘staples’ the middle of the valve flaps together. 

• Non-Surgical: Avoids the need for a heart-lung machine or a large chest incision. 

• Immediate Effect: The reduction in the leak is visible on an ultrasound during the procedure. 

How is the MitraClip Procedure Performed? 

The procedure is performed in a specialised cardiac catheterisation lab under general anaesthetic. A thin, flexible tube is guided from the groin up to the heart. Using advanced X-ray and ultrasound imaging for guidance, the cardiologist passes the catheter through the wall that separates the heart’s upper chambers and positions the clip over the leaky mitral valve. The clip is then closed on the leaflets to secure them, and the catheter is removed. 

The entire process typically takes between two to three hours. Once the device is in place, it becomes a permanent part of the heart, and over time, the heart’s own tissue grows over the clip. 

Who Qualifies for MitraClip in the UK? 

According to clinical guidelines, the MitraClip procedure is primarily reserved for patients with severe, symptomatic mitral regurgitation who are considered at ‘high risk’ or ‘inoperable’ for traditional open-heart surgery. This group often includes older individuals or those with multiple health conditions such as lung disease, kidney problems, or previous heart operations. A multidisciplinary ‘heart team’ makes the final decision based on the patient’s specific valve anatomy. 

• Severe Regurgitation: Usually graded as 3+ or 4+ on a standard echocardiogram. 

• Symptomatic: Patients experiencing significant breathlessness or fatigue despite medication. 

• Surgical Risk: Those for whom the risks of open-heart surgery outweigh the potential benefits. 

• Anatomical Suitability: The valve must have enough healthy tissue for the clip to grip securely. 

What are the Main Causes Treated by MitraClip? 

MitraClip is used to treat two distinct types of mitral regurgitation: ‘primary’ (degenerative) and ‘secondary’ (functional). Primary regurgitation is caused by a structural problem with the valve itself, such as floppy leaflets. Secondary regurgitation occurs when the heart muscle becomes enlarged or weakened often due to a heart attack or heart failure which pulls the healthy valve flaps apart and causes a leak. 

• Mitral Valve Prolapse: The most common cause of primary regurgitation. 

• Heart Failure: The leading cause of secondary (functional) regurgitation. 

• Chordal Rupture: When the tiny strings holding the valve snap, causing a sudden leak. 

• Ageing: Wear and tear on the valve tissue over many decades. 

What are the Benefits and Risks of the Procedure? 

The primary benefit of MitraClip is a significant reduction in symptoms and a lower risk of being hospitalised for heart failure. Because it is less invasive, patients spend less time in the hospital and recover much faster than they would after open surgery. However, like all medical procedures, it carries risks, including minor bleeding at the groin site, a small risk of stroke, or the potential for the clip to detach from the valve. 

• Benefit: Most patients return home within 24 to 48 hours. 

• Benefit: Rapid improvement in breathlessness and energy levels. 

• Risk: A small percentage of patients may still require surgery if the leak is not sufficiently reduced. 

• Risk: A permanent pacemaker may occasionally be needed if the procedure affects the heart’s rhythm. 

Differentiation: MitraClip vs. Open-Heart Surgery 

It is important to differentiate between MitraClip and traditional mitral valve surgery. Open-heart surgery (repair or replacement) remains the ‘gold standard’ for younger, fit patients because it can often eliminate the leak entirely and has better long-term durability. MitraClip is an alternative for those who cannot safely undergo major surgery, focusing on reducing the leak rather than always eliminating it. 

Feature	MitraClip (TEER)	Open-Heart Surgery
Incision	Tiny puncture in the groin.	Large chest incision (Sternotomy).
Recovery	1–2 weeks to full activity.	6–12 weeks to full activity.
Heart-Lung Machine	No.	Yes.
Typical Patient	Frail, elderly, or high-risk.	Younger, lower-risk, or complex cases.
Success Goal	Reduction of leak to mild/moderate.	Complete elimination of the leak.

Conclusion 

The MitraClip procedure is a transformative treatment for individuals with a leaky mitral valve who are unable to face the rigours of open-heart surgery. By providing a minimally invasive way to repair the valve, it offers rapid relief from breathlessness and fatigue, improves quality of life, and helps keep patients out of the hospital. While traditional surgery remains the first choice for those who are fit enough, MitraClip has become an essential tool in modern UK cardiology for managing complex valve disease in high-risk patients. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article has been reviewed by Dr. Stefan Petrov, a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS). Dr. Petrov has extensive clinical experience in general medicine, surgery, and intensive care settings, including the management of patients undergoing minimally invasive cardiac interventions. This guide provides a medically accurate overview of the MitraClip procedure to help you understand how this technology repairs a leaky heart valve.